HTSUF
Price
$28.94
Change
-$3.36 (-10.40%)
Updated
Jun 10 closing price
Capitalization
2.51B
INDV
Price
$15.56
Change
+$0.15 (+0.97%)
Updated
Jul 7, 04:59 PM (EDT)
Capitalization
2.91B
17 days until earnings call
Interact to see
Advertisement

HTSUF vs INDV

Header iconHTSUF vs INDV Comparison
Open Charts HTSUF vs INDVBanner chart's image
Hisamitsu Pharmaceutical
Price$28.94
Change-$3.36 (-10.40%)
Volume$100
Capitalization2.51B
Indivior
Price$15.56
Change+$0.15 (+0.97%)
Volume$25.06K
Capitalization2.91B
HTSUF vs INDV Comparison Chart in %
Loading...
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HTSUF vs. INDV commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HTSUF is a Hold and INDV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (HTSUF: $28.94 vs. INDV: $15.41)
Brand notoriety: HTSUF and INDV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HTSUF: 100% vs. INDV: 203%
Market capitalization -- HTSUF: $2.51B vs. INDV: $2.91B
HTSUF [@Pharmaceuticals: Other] is valued at $2.51B. INDV’s [@Pharmaceuticals: Other] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HTSUF’s FA Score shows that 0 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • HTSUF’s FA Score: 0 green, 5 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than HTSUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HTSUF’s TA Score shows that 4 TA indicator(s) are bullish while INDV’s TA Score has 5 bullish TA indicator(s).

  • HTSUF’s TA Score: 4 bullish, 2 bearish.
  • INDV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HTSUF is a better buy in the short-term than INDV.

Price Growth

HTSUF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while INDV (@Pharmaceuticals: Other) price change was +12.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.70%. For the same industry, the average monthly price growth was +1.26%, and the average quarterly price growth was +79.03%.

Reported Earning Dates

INDV is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.70% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.91B) has a higher market cap than HTSUF($2.51B). INDV has higher P/E ratio than HTSUF: INDV (2102.00) vs HTSUF (25.19). INDV YTD gains are higher at: 23.974 vs. HTSUF (17.839). HTSUF has higher annual earnings (EBITDA): 19.4B vs. INDV (66M). HTSUF has more cash in the bank: 137B vs. INDV (410M). INDV has less debt than HTSUF: INDV (282M) vs HTSUF (1.2B). HTSUF has higher revenues than INDV: HTSUF (134B) vs INDV (1.09B).
HTSUFINDVHTSUF / INDV
Capitalization2.51B2.91B86%
EBITDA19.4B66M29,394%
Gain YTD17.83923.97474%
P/E Ratio25.192102.001%
Revenue134B1.09B12,260%
Total Cash137B410M33,415%
Total Debt1.2B282M426%
FUNDAMENTALS RATINGS
HTSUF vs INDV: Fundamental Ratings
HTSUF
INDV
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
6656
SMR RATING
1..100
8177
PRICE GROWTH RATING
1..100
5639
P/E GROWTH RATING
1..100
9199
SEASONALITY SCORE
1..100
3050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HTSUF's Valuation (90) in the null industry is in the same range as INDV (100). This means that HTSUF’s stock grew similarly to INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (56) in the null industry is in the same range as HTSUF (66). This means that INDV’s stock grew similarly to HTSUF’s over the last 12 months.

INDV's SMR Rating (77) in the null industry is in the same range as HTSUF (81). This means that INDV’s stock grew similarly to HTSUF’s over the last 12 months.

INDV's Price Growth Rating (39) in the null industry is in the same range as HTSUF (56). This means that INDV’s stock grew similarly to HTSUF’s over the last 12 months.

HTSUF's P/E Growth Rating (91) in the null industry is in the same range as INDV (99). This means that HTSUF’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HTSUFINDV
RSI
ODDS (%)
Bullish Trend 5 days ago
17%
Bearish Trend 5 days ago
66%
Stochastic
ODDS (%)
N/A
Bearish Trend 5 days ago
63%
Momentum
ODDS (%)
Bullish Trend 5 days ago
7%
Bullish Trend 5 days ago
62%
MACD
ODDS (%)
Bullish Trend 5 days ago
8%
Bullish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
12%
Bullish Trend 5 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
28%
Bullish Trend 5 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
74%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
74%
Aroon
ODDS (%)
Bullish Trend 5 days ago
3%
Bullish Trend 5 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
HTSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BARAX95.940.86
+0.90%
Baron Asset Retail
HSRUX26.270.23
+0.88%
Carillon Eagle Small Cap Growth R6
BRXVX15.850.08
+0.51%
MFS Blended Research Intl Eq R6
RIDFX26.880.09
+0.34%
American Funds Income Fund of Amer R5
SMNIX27.340.05
+0.18%
Steward Equity Market Neutral I

HTSUF and

Correlation & Price change

A.I.dvisor tells us that HTSUF and CHBRF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUF and CHBRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUF
1D Price
Change %
HTSUF100%
N/A
CHBRF - HTSUF
21%
Poorly correlated
N/A
INIS - HTSUF
10%
Poorly correlated
-8.52%
INDV - HTSUF
5%
Poorly correlated
+0.06%
IPSEF - HTSUF
4%
Poorly correlated
N/A
GTBIF - HTSUF
3%
Poorly correlated
-0.36%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and EBS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+0.06%
EBS - INDV
28%
Poorly correlated
-1.69%
COLL - INDV
23%
Poorly correlated
-0.52%
ELAN - INDV
23%
Poorly correlated
-0.54%
ALKS - INDV
21%
Poorly correlated
-0.52%
ESPR - INDV
21%
Poorly correlated
+1.74%
More